BRCA2 and ovarian carcinoma: Cumulative lifetime risk (to 70 years of age) for invasive breast cancer in women with BRCA1 and BRCA2 mutation is 40 to 85% and for invasive epithelial ovarian cancer is 15 to 65% [1-4].